ArticlePharmacology research & perspectives2023

Suspected oncologic adverse reactions associated with interleukin-23 inhibitors in EudraVigilance: Comparative study and gender distribution.

Fabrizio Calapai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.